CA2083958A1 - Benzoic acid derivatives for treating leukotriene-related disease - Google Patents
Benzoic acid derivatives for treating leukotriene-related diseaseInfo
- Publication number
- CA2083958A1 CA2083958A1 CA002083958A CA2083958A CA2083958A1 CA 2083958 A1 CA2083958 A1 CA 2083958A1 CA 002083958 A CA002083958 A CA 002083958A CA 2083958 A CA2083958 A CA 2083958A CA 2083958 A1 CA2083958 A1 CA 2083958A1
- Authority
- CA
- Canada
- Prior art keywords
- aliphatic
- compound
- aryl
- alkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53438890A | 1990-06-07 | 1990-06-07 | |
| US534,388 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2083958A1 true CA2083958A1 (en) | 1991-12-08 |
Family
ID=24129833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002083958A Abandoned CA2083958A1 (en) | 1990-06-07 | 1991-05-15 | Benzoic acid derivatives for treating leukotriene-related disease |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0532550A1 (fi) |
| JP (1) | JPH05507475A (fi) |
| KR (1) | KR930700445A (fi) |
| CN (1) | CN1058016A (fi) |
| AU (1) | AU7901791A (fi) |
| CA (1) | CA2083958A1 (fi) |
| FI (1) | FI925544A (fi) |
| HU (1) | HUT64748A (fi) |
| IE (2) | IE911913A1 (fi) |
| IL (1) | IL98388A0 (fi) |
| MA (1) | MA22196A1 (fi) |
| MX (1) | MX26142A (fi) |
| PL (1) | PL290586A1 (fi) |
| PT (1) | PT97912A (fi) |
| WO (1) | WO1991018880A1 (fi) |
| ZA (1) | ZA914323B (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4226493A (en) * | 1992-05-01 | 1993-11-29 | Smithkline Beecham Corporation | Leukotriene antagonists |
| WO1995015950A1 (en) * | 1993-12-08 | 1995-06-15 | Smithkline Beecham Corporation | Compounds |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| WO1994014442A1 (en) * | 1992-12-23 | 1994-07-07 | Smithkline Beecham Corporation | Substituted pyridyl compounds useful as leukotriene antagonists |
| BR9507459A (pt) * | 1994-04-13 | 1997-11-11 | Hoffmann La Roche | Antagonistas á base de piridino-leucotrieno b4 substituído |
| US7297357B2 (en) * | 2001-03-27 | 2007-11-20 | Meiji Seika Kaisha, Ltd. | Process for producing puffed snack and production apparatus therefor |
| ES2622522T3 (es) | 2003-08-26 | 2017-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Inhibidores de la actividad proteasa de serina y su uso en métodos y composiciones para el tratamiento de infecciones bacterianas |
| US8093253B2 (en) | 2008-03-06 | 2012-01-10 | Hoffmann-La Roche Inc. | Leukotriene B4 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4563446A (en) * | 1983-07-27 | 1986-01-07 | Takeda Chemical Industries, Ltd. | Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines |
| GB8505285D0 (en) * | 1985-03-01 | 1985-04-03 | Beecham Group Plc | Compounds |
-
1991
- 1991-05-15 HU HU9203866A patent/HUT64748A/hu unknown
- 1991-05-15 AU AU79017/91A patent/AU7901791A/en not_active Abandoned
- 1991-05-15 CA CA002083958A patent/CA2083958A1/en not_active Abandoned
- 1991-05-15 JP JP91509448A patent/JPH05507475A/ja active Pending
- 1991-05-15 EP EP91909997A patent/EP0532550A1/en not_active Withdrawn
- 1991-05-15 KR KR1019920703090A patent/KR930700445A/ko not_active Application Discontinuation
- 1991-05-15 WO PCT/US1991/003399 patent/WO1991018880A1/en not_active Application Discontinuation
- 1991-06-03 MA MA22442A patent/MA22196A1/fr unknown
- 1991-06-05 IE IE191391A patent/IE911913A1/en unknown
- 1991-06-05 IL IL98388A patent/IL98388A0/xx unknown
- 1991-06-05 IE IE191291A patent/IE911912A1/en unknown
- 1991-06-06 MX MX2614291A patent/MX26142A/es unknown
- 1991-06-06 ZA ZA914323A patent/ZA914323B/xx unknown
- 1991-06-07 PL PL29058691A patent/PL290586A1/xx unknown
- 1991-06-07 PT PT97912A patent/PT97912A/pt not_active Application Discontinuation
- 1991-06-07 CN CN91104564A patent/CN1058016A/zh active Pending
-
1992
- 1992-12-07 FI FI925544A patent/FI925544A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0532550A1 (en) | 1993-03-24 |
| FI925544A0 (fi) | 1992-12-07 |
| HUT64748A (en) | 1994-02-28 |
| JPH05507475A (ja) | 1993-10-28 |
| AU7901791A (en) | 1991-12-31 |
| MA22196A1 (fr) | 1992-04-01 |
| ZA914323B (en) | 1992-06-24 |
| IE911912A1 (en) | 1991-12-18 |
| IE911913A1 (en) | 1991-12-18 |
| HU9203866D0 (en) | 1993-03-29 |
| FI925544A (fi) | 1992-12-07 |
| MX26142A (es) | 1994-02-28 |
| WO1991018880A1 (en) | 1991-12-12 |
| CN1058016A (zh) | 1992-01-22 |
| IL98388A0 (en) | 1992-07-15 |
| PT97912A (pt) | 1992-03-31 |
| PL290586A1 (en) | 1992-04-06 |
| KR930700445A (ko) | 1993-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000510481A (ja) | ニコチンアミド誘導体 | |
| JP2002520317A (ja) | ２−アミノピリジン誘導体、その医薬としての使用及びそれを含有する医薬組成物 | |
| JP3341019B2 (ja) | 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された単環式アリール化合物 | |
| AP333A (en) | Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases. | |
| CA2083958A1 (en) | Benzoic acid derivatives for treating leukotriene-related disease | |
| AU655428B2 (en) | Benzoic acid derivatives | |
| JP2005507381A (ja) | 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト | |
| CA2083956A1 (en) | Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| WO1991018879A1 (en) | Phthalamic acids and their isomers for treating leukotriene-related diseases | |
| US5656636A (en) | Pyridine compounds for treating leukotriene-related diseases | |
| WO1993010780A1 (en) | Heterocyclic-substituted pyridine compounds and uses | |
| WO1993022285A1 (en) | Leukotriene antagonists | |
| WO1993011768A1 (en) | Pyridyl compounds for psoriasis treatment | |
| JPH09505605A (ja) | 置換ピリジンロイコトリエンｂ▲下４▼拮抗物質 | |
| WO1995015950A1 (en) | Compounds | |
| WO1992017172A1 (en) | Disubstituted naphthalenes | |
| JPH08505148A (ja) | ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |